Toyserkani et al., 2016 - Google Patents
Cell-assisted lipotransfer using autologous adipose-derived stromal cells for alleviation of breast cancer-related lymphedemaToyserkani et al., 2016
View HTML- Document ID
- 898070014996732201
- Author
- Toyserkani N
- Jensen C
- Sheikh S
- Sørensen J
- Publication year
- Publication venue
- Stem Cells Translational Medicine
External Links
Snippet
Lymphedema is one of the most frequent side effects following cancer treatment, and treatment opportunities for it are currently lacking. Stem cell therapy has been proposed as a possible novel treatment modality. This study was the first case in which freshly isolated …
- 210000004027 cells 0 title abstract description 22
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Toyserkani et al. | Cell-assisted lipotransfer using autologous adipose-derived stromal cells for alleviation of breast cancer-related lymphedema | |
| Giorgino et al. | Knee osteoarthritis: epidemiology, pathogenesis, and mesenchymal stem cells: what else is new? An update | |
| Toyserkani et al. | Treatment of breast cancer-related lymphedema with adipose-derived regenerative cells and fat grafts: a feasibility and safety study | |
| Kølle et al. | Enrichment of autologous fat grafts with ex-vivo expanded adipose tissue-derived stem cells for graft survival: a randomised placebo-controlled trial | |
| Jo et al. | Intratendinous injection of autologous adipose tissue-derived mesenchymal stem cells for the treatment of rotator cuff disease: a first-in-human trial | |
| Li et al. | Mesenchymal stem cells: a double-edged sword in regulating immune responses | |
| Bansal et al. | RETRACTED ARTICLE: Intra-articular injection in the knee of adipose derived stromal cells (stromal vascular fraction) and platelet rich plasma for osteoarthritis | |
| Gontijo-de-Amorim et al. | Mechanical supplementation with the stromal vascular fraction yields improved volume retention in facial lipotransfer: a 1-year comparative study | |
| Thangarajah et al. | IFATS collection: adipose stromal cells adopt a proangiogenic phenotype under the influence of hypoxia | |
| Carrasco et al. | The role of extracellular vesicles in cutaneous remodeling and hair follicle dynamics | |
| Bussche et al. | Peripheral blood-derived mesenchymal stromal cells promote angiogenesis via paracrine stimulation of vascular endothelial growth factor secretion in the equine model | |
| Derby et al. | Adipose-derived stem cell to epithelial stem cell transdifferentiation: a mechanism to potentially improve understanding of fat grafting's impact on skin rejuvenation | |
| Kraskiewicz et al. | Can supernatant from immortalized adipose tissue MSC replace cell therapy? An in vitro study in chronic wounds model | |
| Massa et al. | Interaction between breast cancer cells and adipose tissue cells derived from fat grafting | |
| Gupta et al. | Cell-free stem cell-derived extract formulation for regenerative medicine applications | |
| Zhao et al. | Mesenchymal stem cell transplantation improves regional cardiac remodeling following ovine infarction | |
| Li et al. | Mesenchymal stem cells modified with angiopoietin-1 gene promote wound healing | |
| Sheng et al. | Adipose tissue‐derived stem cells (ADSC s) transplantation promotes regeneration of expanded skin using a tissue expansion model | |
| Rose et al. | Fluorine-19 labeling of stromal vascular fraction cells for clinical imaging applications | |
| Xu et al. | Autologous transplantation of bone marrow–derived mesenchymal stem cells: a promising therapeutic strategy for prevention of skin‐graft contraction | |
| Wahl et al. | VEGF released by deferoxamine preconditioned mesenchymal stem cells seeded on collagen-GAG substrates enhances neovascularization | |
| Arici et al. | Autologous immuno magnetically selected CD133+ stem cells in the treatment of no-option critical limb ischemia: clinical and contrast enhanced ultrasound assessed results in eight patients | |
| Iso et al. | Distinct mobilization of circulating CD271+ mesenchymal progenitors from hematopoietic progenitors during aging and after myocardial infarction | |
| Piejko et al. | Adipose-derived stromal cells seeded on integra® dermal regeneration template improve post-burn wound reconstruction | |
| WO2018148669A2 (en) | Biological scaffolds, products containing biological scaffolds and methods of using the same |